News About: Goverment
Government's drug price slash to litigate this week.
More than 10 drug companies are going to take part in the joint administrative litigation against unfair slash of the drug prices earlier determined by the MOHW. The MOHW urged the drug industry not to raise any litig...
Some pharmacies still steeped in irregularities
Despite the Pharmaceutical Affairs Law stipulating the regulations on the establishment and registration of an eligible pharmacy, new proprietors of pharmacy, who closed down his/her pharmacy due to the charge of coll...
MOHW to inspect clinical pathology and other sections.
The MOHW announced to take a special inspection against the clinical pathology laboratory and other sections where the medical charges could be highly duplicated.
The MOHW reviewed and find out any overlapped NHI a...
Pharmacy where 70% convergency in prescriptions primarily to inspect.
The pharmacy where almost exclusively dispensing over 70% of the prescriptions issued by specific medical institutions will be appointed preferentially to inspect more than once every quarter.
The MOHW set up the p...
150 wholesalers are still in pending status for KGSP accreditation
The Korea Food and Drug Administration (KFDA) says the number of KGSP-accredited wholesalers totaled 992 as of July 1.
Currently, 150 wholesalers are still in application for acquisition of the Korea Good Supply Pr...
Overall discussion on separation of drug dispensing from medical practice outlined
After a two-year implementation of a new system of separating drug dispensing from medical practice (SDP function), the quality of pharmacies, such as drug guidance, has been significantly enhanced but the collusion a...
Drug industry strongly denounced government's price slash.
Under the theme of NHI financial stabilization measures, the government has shown an one-side price slashing policy, eventually provoking the drug industry a repulsion so harsh as to put a court fight. Even the govern...
43 ingredients subject to bioequivalence test in 2004
The Korea Food and Drug Administration (KFDA) said the bioequivalence tests of 43 ingredients with narrow therapeutic thresfolds will take effect on 43 from July 1, 2004 on a mandatory basis.
Ingredients to be inc...
KHIDI established ground works for clinical tests.
The Korea Health Industry Development Institute (KHIDI) has prepared a ground work for the future domestic clinical studies over overall health industrial products and drugs.
Following the strategic tie-up with th...
Waiver of bioequivalence tests for 4,600 items eyed
The Korea Food and Administration (KFDA) announced some items whose bioequivalence tests are deemed to unnecessarily and impossibly undertaken may be replaced by the following tests: physicochemical equivalence tests,...
